Clinical Trial Update: Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of somatropin in patients with SHOX deficiency and Turner syndrome has completed. Sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shox Deficiency
• Turner Syndrome

Drugs mentioned

• HUMATROPE (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Failure to Thrive | Phase 3 | Status: COMPLETED